| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GABA-A receptor activity | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 4.88e-25 | 19 | 82 | 12 | GO:0004890 |
| GeneOntologyMolecularFunction | GABA receptor activity | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 6.20e-24 | 22 | 82 | 12 | GO:0016917 |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | GABRB1 GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 8.66e-23 | 18 | 82 | 11 | GO:0022851 |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 HTR1F HTR2B GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 4.04e-18 | 100 | 82 | 14 | GO:0030594 |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 9.30e-18 | 11 | 82 | 8 | GO:0008503 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 3.36e-17 | 65 | 82 | 12 | GO:0022835 |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 3.36e-17 | 65 | 82 | 12 | GO:0022824 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | GABRB1 GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 9.16e-17 | 50 | 82 | 11 | GO:0099095 |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 SLC12A1 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 1.03e-16 | 125 | 82 | 14 | GO:0015108 |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 2.78e-16 | 103 | 82 | 13 | GO:0005253 |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 2.95e-16 | 77 | 82 | 12 | GO:0005230 |
| GeneOntologyMolecularFunction | chloride channel activity | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 1.19e-15 | 86 | 82 | 12 | GO:0005254 |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 SLC12A1 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 1.53e-15 | 151 | 82 | 14 | GO:0008509 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 SLC12A1 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 8.83e-15 | 171 | 82 | 14 | GO:0015103 |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | GABRB1 GABRD GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 2.86e-14 | 57 | 82 | 10 | GO:1904315 |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | GABRB1 GABRD GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 4.94e-14 | 60 | 82 | 10 | GO:0099529 |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | GABRB1 GABRD GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 5.17e-13 | 75 | 82 | 10 | GO:0098960 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 2.16e-11 | 193 | 82 | 12 | GO:0015276 |
| GeneOntologyMolecularFunction | ligand-gated channel activity | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 2.75e-11 | 197 | 82 | 12 | GO:0022834 |
| GeneOntologyMolecularFunction | gated channel activity | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 TMC6 KCNQ3 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 8.07e-11 | 334 | 82 | 14 | GO:0022836 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 TMC6 KCNQ3 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 5.13e-10 | 459 | 82 | 15 | GO:0005216 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRB1 OR3A1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 OR4C3 HTR1F HTR2B OR4C16 OR4X2 FGFR2 ADGRE1 GRM8 ADGRG4 GABRA1 GABRA2 GABRR3 GABRA3 LRP8 GABRA4 GABRA6 | 2.96e-09 | 1353 | 82 | 23 | GO:0004888 |
| GeneOntologyMolecularFunction | channel activity | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 TMC6 KCNQ3 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 3.21e-09 | 525 | 82 | 15 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 TMC6 KCNQ3 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 3.29e-09 | 526 | 82 | 15 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 SLC12A1 TMC6 KCNQ3 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 1.18e-07 | 793 | 82 | 16 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 SLC12A1 KCNQ3 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 3.98e-07 | 758 | 82 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 SLC12A1 ABCB5 TMC6 KCNQ3 SLC49A3 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 1.07e-06 | 1180 | 82 | 18 | GO:0022857 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 2.64e-06 | 24 | 82 | 4 | GO:0099507 | |
| GeneOntologyMolecularFunction | transporter activity | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 SLC12A1 ABCB5 TMC6 KCNQ3 SLC49A3 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 3.77e-06 | 1289 | 82 | 18 | GO:0005215 |
| GeneOntologyMolecularFunction | diazepam binding | 4.98e-05 | 3 | 82 | 2 | GO:0050809 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent, lubricant activity | 9.94e-05 | 4 | 82 | 2 | GO:0030197 | |
| GeneOntologyMolecularFunction | histone H3K36 trimethyltransferase activity | 1.65e-04 | 5 | 82 | 2 | GO:0140955 | |
| GeneOntologyMolecularFunction | histone H3K9 monomethyltransferase activity | 4.59e-04 | 8 | 82 | 2 | GO:0140948 | |
| GeneOntologyMolecularFunction | histone H3K9me2 methyltransferase activity | 7.34e-04 | 10 | 82 | 2 | GO:0140947 | |
| GeneOntologyMolecularFunction | histone H3K9 methyltransferase activity | 1.26e-03 | 13 | 82 | 2 | GO:0046974 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 1.26e-03 | 13 | 82 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | serotonin binding | 1.26e-03 | 13 | 82 | 2 | GO:0051378 | |
| GeneOntologyMolecularFunction | E-box binding | 2.02e-03 | 61 | 82 | 3 | GO:0070888 | |
| GeneOntologyMolecularFunction | GABA receptor binding | 3.02e-03 | 20 | 82 | 2 | GO:0050811 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | GABRB1 OR3A1 OR4C3 HTR1F HTR2B OR4C16 OR4X2 ADGRE1 GRM8 ADGRG4 | 3.28e-03 | 884 | 82 | 10 | GO:0004930 |
| GeneOntologyMolecularFunction | amine binding | 3.33e-03 | 21 | 82 | 2 | GO:0043176 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor activity | 3.65e-03 | 22 | 82 | 2 | GO:0004993 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 5.01e-03 | 84 | 82 | 3 | GO:0003684 | |
| GeneOntologyMolecularFunction | histone acetyltransferase binding | 6.29e-03 | 29 | 82 | 2 | GO:0035035 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 6.09e-21 | 35 | 83 | 12 | GO:0007214 |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 SLC12A1 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 1.62e-17 | 112 | 83 | 14 | GO:1902476 |
| GeneOntologyBiologicalProcess | chloride transport | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 SLC12A1 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 1.12e-16 | 128 | 83 | 14 | GO:0006821 |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 SLC12A1 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 2.15e-16 | 134 | 83 | 14 | GO:0098661 |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 SLC12A1 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 1.42e-15 | 153 | 83 | 14 | GO:0098656 |
| GeneOntologyBiologicalProcess | inorganic anion transport | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 SLC12A1 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 1.40e-14 | 180 | 83 | 14 | GO:0015698 |
| GeneOntologyBiologicalProcess | monoatomic anion transport | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 SLC12A1 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 1.76e-14 | 183 | 83 | 14 | GO:0006820 |
| GeneOntologyBiologicalProcess | inhibitory synapse assembly | 2.65e-13 | 30 | 83 | 8 | GO:1904862 | |
| GeneOntologyBiologicalProcess | synaptic transmission, GABAergic | GABRD GABRG1 GABRG2 GABRG3 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 1.58e-11 | 74 | 83 | 9 | GO:0051932 |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 1.54e-10 | 180 | 83 | 11 | GO:0060078 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 HTR1F HTR2B SHANK2 KCNQ3 GRM8 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 LRP8 GABRA4 GABRA6 | 3.77e-09 | 931 | 83 | 19 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 HTR1F HTR2B SHANK2 KCNQ3 GRM8 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 LRP8 GABRA4 GABRA6 | 3.77e-09 | 931 | 83 | 19 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 HTR1F HTR2B SHANK2 KCNQ3 GRM8 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 LRP8 GABRA4 GABRA6 | 4.33e-09 | 939 | 83 | 19 | GO:0099537 |
| GeneOntologyBiologicalProcess | synaptic signaling | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 HTR1F HTR2B SHANK2 KCNQ3 GRM8 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 LRP8 GABRA4 GABRA6 | 8.12e-09 | 976 | 83 | 19 | GO:0099536 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRB1 JPH1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 HTR2B SLC12A1 BHLHA15 TMC6 JPH2 KCNQ3 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 1.21e-08 | 1115 | 83 | 20 | GO:0034220 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | GABRB1 JPH1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 HTR2B SLC12A1 BHLHA15 JPH2 KCNQ3 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 1.58e-08 | 1017 | 83 | 19 | GO:0098660 |
| GeneOntologyBiologicalProcess | synapse assembly | GABRG1 GABRG2 GABRG3 SHANK2 SETD5 CNTN5 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 4.28e-08 | 308 | 83 | 11 | GO:0007416 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 ABCB5 KCNQ3 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 4.66e-08 | 559 | 83 | 14 | GO:0042391 |
| GeneOntologyBiologicalProcess | synapse organization | GABRG1 GABRG2 GABRG3 SHANK2 SETD5 CNTN5 FGFR2 WASF1 SLC1A1 GABRA1 GABRA2 GABRA3 LRP8 GABRA4 GABRA6 | 8.48e-08 | 685 | 83 | 15 | GO:0050808 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRB1 JPH1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 HTR2B SLC12A1 BHLHA15 TMC6 JPH2 KCNQ3 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 3.69e-07 | 1374 | 83 | 20 | GO:0006811 |
| GeneOntologyBiologicalProcess | cell junction organization | GABRG1 GABRG2 GABRG3 SHANK2 SETD5 BHLHA15 CNTN5 FGFR2 WASF1 SLC1A1 GABRA1 GABRA2 GABRA3 LRP8 GABRA4 GABRA6 | 1.42e-06 | 974 | 83 | 16 | GO:0034330 |
| GeneOntologyBiologicalProcess | cellular response to histamine | 2.17e-06 | 7 | 83 | 3 | GO:0071420 | |
| GeneOntologyBiologicalProcess | response to histamine | 1.35e-05 | 12 | 83 | 3 | GO:0034776 | |
| GeneOntologyBiologicalProcess | cell junction assembly | GABRG1 GABRG2 GABRG3 SHANK2 SETD5 CNTN5 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 1.71e-05 | 569 | 83 | 11 | GO:0034329 |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | GABRG3 TIGAR RBM22 HTR2B SHANK2 KCNQ3 XRCC1 SLC1A1 PCNA LRP8 | 4.82e-05 | 525 | 83 | 10 | GO:0009410 |
| GeneOntologyBiologicalProcess | cellular response to ammonium ion | 2.37e-04 | 6 | 83 | 2 | GO:0071242 | |
| GeneOntologyBiologicalProcess | response to ammonium ion | 3.32e-04 | 7 | 83 | 2 | GO:0060359 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 7.22e-04 | 605 | 83 | 9 | GO:0071407 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 3.29e-25 | 19 | 83 | 12 | GO:1902711 |
| GeneOntologyCellularComponent | GABA receptor complex | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 1.91e-24 | 21 | 83 | 12 | GO:1902710 |
| GeneOntologyCellularComponent | chloride channel complex | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 4.10e-18 | 57 | 83 | 12 | GO:0034707 |
| GeneOntologyCellularComponent | GABA-ergic synapse | GABRB1 GABRD GABRG2 GABRG3 GABRR2 CNTN5 GRM8 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 8.67e-14 | 164 | 83 | 13 | GO:0098982 |
| GeneOntologyCellularComponent | dendrite membrane | 5.32e-11 | 56 | 83 | 8 | GO:0032590 | |
| GeneOntologyCellularComponent | receptor complex | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 HTR2B PTPRQ FGFR2 CD200R1L GABRA1 GABRA2 GABRR3 GABRA3 LRP8 GABRA4 GABRA6 | 1.04e-10 | 581 | 83 | 17 | GO:0043235 |
| GeneOntologyCellularComponent | postsynaptic membrane | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 SHANK2 GABRA1 GABRA2 GABRR3 GABRA3 LRP8 GABRA4 GABRA6 | 6.60e-10 | 405 | 83 | 14 | GO:0045211 |
| GeneOntologyCellularComponent | synaptic membrane | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 SHANK2 CNTN5 GRM8 GABRA1 GABRA2 GABRR3 GABRA3 LRP8 GABRA4 GABRA6 | 1.00e-09 | 583 | 83 | 16 | GO:0097060 |
| GeneOntologyCellularComponent | neuron projection membrane | 1.23e-09 | 82 | 83 | 8 | GO:0032589 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 KCNQ3 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 3.04e-09 | 378 | 83 | 13 | GO:0034702 |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 KCNQ3 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 1.39e-07 | 523 | 83 | 13 | GO:1902495 |
| GeneOntologyCellularComponent | dendrite | GABRB1 GABRD GABRG1 GABRG2 GABRG3 HTR1F HTR2B SHANK2 KCNQ3 SLC1A1 GABRA1 GABRA2 GABRA3 LRP8 GABRA4 GABRA6 | 2.22e-07 | 858 | 83 | 16 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | GABRB1 GABRD GABRG1 GABRG2 GABRG3 HTR1F HTR2B SHANK2 KCNQ3 SLC1A1 GABRA1 GABRA2 GABRA3 LRP8 GABRA4 GABRA6 | 2.29e-07 | 860 | 83 | 16 | GO:0097447 |
| GeneOntologyCellularComponent | transporter complex | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 KCNQ3 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 2.47e-07 | 550 | 83 | 13 | GO:1990351 |
| GeneOntologyCellularComponent | somatodendritic compartment | GABRB1 GABRD GABRG1 GABRG2 GABRG3 CNTNAP3B HTR1F HTR2B SHANK2 CNTNAP3 KCNQ3 GRM8 SLC1A1 GABRA1 GABRA2 GABRA3 LRP8 GABRA4 GABRA6 | 2.48e-07 | 1228 | 83 | 19 | GO:0036477 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.35e-06 | 201 | 83 | 8 | GO:0099634 | |
| GeneOntologyCellularComponent | leading edge membrane | 1.88e-06 | 210 | 83 | 8 | GO:0031256 | |
| GeneOntologyCellularComponent | postsynapse | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 SHANK2 WASF1 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 LRP8 GABRA4 GABRA6 | 2.12e-06 | 1018 | 83 | 16 | GO:0098794 |
| GeneOntologyCellularComponent | cell projection membrane | GABRG1 GABRG2 GABRG3 SHANK2 MUC17 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 7.95e-06 | 431 | 83 | 10 | GO:0031253 |
| GeneOntologyCellularComponent | cell leading edge | GABRG1 GABRG2 GABRG3 WASF1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 1.63e-04 | 500 | 83 | 9 | GO:0031252 |
| GeneOntologyCellularComponent | postsynaptic specialization | GABRB1 GABRG2 SHANK2 GABRA1 GABRA2 GABRA3 LRP8 GABRA4 GABRA6 | 1.71e-04 | 503 | 83 | 9 | GO:0099572 |
| GeneOntologyCellularComponent | presynaptic active zone | 2.48e-04 | 141 | 83 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 2.64e-04 | 78 | 83 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | neuronal cell body | GABRD CNTNAP3B HTR2B SHANK2 CNTNAP3 KCNQ3 GRM8 SLC1A1 GABRA2 LRP8 GABRA6 | 4.52e-04 | 835 | 83 | 11 | GO:0043025 |
| GeneOntologyCellularComponent | junctional membrane complex | 5.51e-04 | 9 | 83 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 6.87e-04 | 10 | 83 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | axon | GABRD GABRG2 GABRR2 CNTNAP3B SHANK2 CNTN5 CNTNAP3 KCNQ3 SLC1A1 GABRA2 LRP8 | 7.75e-04 | 891 | 83 | 11 | GO:0030424 |
| GeneOntologyCellularComponent | presynaptic membrane | 8.24e-04 | 277 | 83 | 6 | GO:0042734 | |
| GeneOntologyCellularComponent | Golgi lumen | 9.37e-04 | 109 | 83 | 4 | GO:0005796 | |
| GeneOntologyCellularComponent | cell body | GABRD CNTNAP3B HTR2B SHANK2 CNTNAP3 KCNQ3 GRM8 SLC1A1 GABRA2 LRP8 GABRA6 | 1.09e-03 | 929 | 83 | 11 | GO:0044297 |
| GeneOntologyCellularComponent | membrane protein complex | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 SHC1 KCNQ3 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 2.19e-03 | 1498 | 83 | 14 | GO:0098796 |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 5.20e-03 | 88 | 83 | 3 | GO:0016529 | |
| GeneOntologyCellularComponent | inhibitory synapse | 6.72e-03 | 31 | 83 | 2 | GO:0060077 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 1.46e-06 | 15 | 31 | 4 | HP:0007207 | |
| HumanPheno | Visually-induced seizure | 3.24e-06 | 18 | 31 | 4 | HP:0020216 | |
| HumanPheno | Reflex seizure | 7.61e-06 | 22 | 31 | 4 | HP:0020207 | |
| HumanPheno | Morning myoclonic jerks | 3.26e-05 | 11 | 31 | 3 | HP:0007000 | |
| HumanPheno | Obsessive-compulsive trait | 4.06e-05 | 33 | 31 | 4 | HP:0008770 | |
| HumanPheno | Facial tics | 8.84e-05 | 15 | 31 | 3 | HP:0011468 | |
| HumanPheno | Focal impaired awareness seizure | 9.01e-05 | 126 | 31 | 6 | HP:0002384 | |
| HumanPheno | Infection-related seizure | 1.96e-04 | 145 | 31 | 6 | HP:0032892 | |
| HumanPheno | Seizure precipitated by febrile infection | 1.96e-04 | 145 | 31 | 6 | HP:0032894 | |
| HumanPheno | Febrile seizure (within the age range of 3 months to 6 years) | 1.96e-04 | 145 | 31 | 6 | HP:0002373 | |
| HumanPheno | EEG with polyspike wave complexes | 1.96e-04 | 49 | 31 | 4 | HP:0002392 | |
| HumanPheno | Bilateral tonic-clonic seizure with generalized onset | 2.48e-04 | 52 | 31 | 4 | HP:0025190 | |
| HumanPheno | Compulsive behaviors | 3.13e-04 | 158 | 31 | 6 | HP:0000722 | |
| HumanPheno | Tibial torsion | 3.33e-04 | 23 | 31 | 3 | HP:0100694 | |
| MousePheno | abnormal GABA-mediated receptor currents | 2.06e-08 | 18 | 69 | 5 | MP:0004008 | |
| MousePheno | impaired behavioral response to xenobiotic | 5.45e-05 | 83 | 69 | 5 | MP:0009747 | |
| MousePheno | abnormal myocardial trabeculae morphology | 7.57e-05 | 144 | 69 | 6 | MP:0002189 | |
| MousePheno | abnormal decidualization | 8.91e-05 | 18 | 69 | 3 | MP:0003845 | |
| Domain | GABAA/Glycine_rcpt | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 2.46e-23 | 23 | 81 | 12 | IPR006028 |
| Domain | Neurotransmitter_ion_chnl_CS | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 4.85e-19 | 45 | 81 | 12 | IPR018000 |
| Domain | Neur_chan_memb | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 6.54e-19 | 46 | 81 | 12 | PF02932 |
| Domain | Neur_chan_LBD | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 8.75e-19 | 47 | 81 | 12 | PF02931 |
| Domain | NEUROTR_ION_CHANNEL | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 8.75e-19 | 47 | 81 | 12 | PS00236 |
| Domain | Neurotrans-gated_channel_TM | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 8.75e-19 | 47 | 81 | 12 | IPR006029 |
| Domain | - | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 8.75e-19 | 47 | 81 | 12 | 2.70.170.10 |
| Domain | Neur_channel | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 8.75e-19 | 47 | 81 | 12 | IPR006201 |
| Domain | Neur_chan_lig-bd | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 8.75e-19 | 47 | 81 | 12 | IPR006202 |
| Domain | GABAAa_rcpt | 8.09e-12 | 6 | 81 | 5 | IPR001390 | |
| Domain | GABBAg_rcpt | 7.86e-08 | 3 | 81 | 3 | IPR005437 | |
| Domain | SEA | 3.18e-07 | 14 | 81 | 4 | SM00200 | |
| Domain | EGF_3 | 8.05e-07 | 235 | 81 | 9 | PS50026 | |
| Domain | EGF | 8.05e-07 | 235 | 81 | 9 | SM00181 | |
| Domain | EGF-like_dom | 1.30e-06 | 249 | 81 | 9 | IPR000742 | |
| Domain | EGF_1 | 1.59e-06 | 255 | 81 | 9 | PS00022 | |
| Domain | EGF_2 | 2.18e-06 | 265 | 81 | 9 | PS01186 | |
| Domain | SEA | 2.73e-06 | 23 | 81 | 4 | PS50024 | |
| Domain | SEA_dom | 2.73e-06 | 23 | 81 | 4 | IPR000082 | |
| Domain | EGF-like_CS | 1.74e-05 | 261 | 81 | 8 | IPR013032 | |
| Domain | Junctophilin | 1.11e-04 | 4 | 81 | 2 | IPR017191 | |
| Domain | SEA | 1.14e-04 | 22 | 81 | 3 | PF01390 | |
| Domain | FIBRINOGEN_C_1 | 3.56e-04 | 32 | 81 | 3 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 3.56e-04 | 32 | 81 | 3 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 3.56e-04 | 32 | 81 | 3 | PS51406 | |
| Domain | Growth_fac_rcpt_ | 5.86e-04 | 156 | 81 | 5 | IPR009030 | |
| Domain | LAM_G_DOMAIN | 5.94e-04 | 38 | 81 | 3 | PS50025 | |
| Domain | 5HT_rcpt | 6.56e-04 | 9 | 81 | 2 | IPR002231 | |
| Domain | Laminin_G_2 | 6.92e-04 | 40 | 81 | 3 | PF02210 | |
| Domain | Galactose-bd-like | 7.44e-04 | 94 | 81 | 4 | IPR008979 | |
| Domain | LamG | 9.16e-04 | 44 | 81 | 3 | SM00282 | |
| Domain | MORN | 1.63e-03 | 14 | 81 | 2 | SM00698 | |
| Domain | MORN | 1.88e-03 | 15 | 81 | 2 | IPR003409 | |
| Domain | MORN | 1.88e-03 | 15 | 81 | 2 | PF02493 | |
| Domain | - | 1.88e-03 | 15 | 81 | 2 | 3.30.70.960 | |
| Domain | Laminin_G | 2.04e-03 | 58 | 81 | 3 | IPR001791 | |
| Domain | EGF | 2.20e-03 | 126 | 81 | 4 | PF00008 | |
| Domain | ConA-like_dom | 2.63e-03 | 219 | 81 | 5 | IPR013320 | |
| Domain | His_PPase_superfam | 3.36e-03 | 20 | 81 | 2 | IPR029033 | |
| Domain | - | 3.36e-03 | 20 | 81 | 2 | 3.40.50.1240 | |
| Domain | FA58C | 3.70e-03 | 21 | 81 | 2 | SM00231 | |
| Domain | FA58C_3 | 3.70e-03 | 21 | 81 | 2 | PS50022 | |
| Domain | FA58C_1 | 3.70e-03 | 21 | 81 | 2 | PS01285 | |
| Domain | FA58C_2 | 3.70e-03 | 21 | 81 | 2 | PS01286 | |
| Domain | - | 3.93e-03 | 73 | 81 | 3 | 2.60.120.260 | |
| Domain | F5_F8_type_C | 4.82e-03 | 24 | 81 | 2 | PF00754 | |
| Domain | FA58C | 4.82e-03 | 24 | 81 | 2 | IPR000421 | |
| Domain | FBG | 6.99e-03 | 29 | 81 | 2 | SM00186 | |
| Domain | - | 7.47e-03 | 30 | 81 | 2 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 7.47e-03 | 30 | 81 | 2 | IPR014716 | |
| Domain | - | 8.17e-03 | 95 | 81 | 3 | 2.60.120.200 | |
| Domain | EGF_Ca-bd_CS | 8.65e-03 | 97 | 81 | 3 | IPR018097 | |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | GABRB1 GABRD GABRG1 GABRG2 GABRG3 SHC1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 7.48e-18 | 38 | 64 | 11 | M39854 |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 7.33e-17 | 31 | 64 | 10 | M39369 |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | GABRB1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 1.13e-13 | 60 | 64 | 10 | MM15708 |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | GABRB1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 1.13e-13 | 60 | 64 | 10 | M976 |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 HTR1F HTR2B GRM8 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 1.43e-11 | 272 | 64 | 14 | M13380 |
| Pathway | WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 1.29e-10 | 119 | 64 | 10 | M48309 |
| Pathway | BIOCARTA_FLUMAZENIL_PATHWAY | 2.04e-10 | 9 | 64 | 5 | M22034 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 4.07e-10 | 10 | 64 | 5 | M477 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | GABRB1 GABRD GABRG1 GABRG2 HTR1F HTR2B SHANK2 CNTN5 CNTNAP3 GRM8 GABRA1 GABRA2 GABRA3 GABRA4 | 7.55e-10 | 367 | 64 | 14 | M48346 |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | GABRB1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 8.54e-10 | 144 | 64 | 10 | MM14501 |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | GABRB1 GABRG2 GABRG3 GABRR2 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 2.42e-09 | 211 | 64 | 11 | MM14502 |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | GABRB1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 2.60e-08 | 205 | 64 | 10 | M752 |
| Pathway | REACTOME_NEURONAL_SYSTEM | GABRB1 GABRG2 GABRG3 GABRR2 SHANK2 KCNQ3 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 3.10e-08 | 411 | 64 | 13 | M735 |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | GABRB1 GABRG2 GABRG3 GABRR2 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 3.14e-08 | 270 | 64 | 11 | M15514 |
| Pathway | BIOCARTA_GABA_PATHWAY | 7.95e-08 | 10 | 64 | 4 | MM1401 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | GABRB1 GABRG2 GABRG3 GABRR2 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 2.80e-07 | 335 | 64 | 11 | MM14503 |
| Pathway | REACTOME_SIGNALING_BY_ERBB4 | 6.26e-06 | 58 | 64 | 5 | M544 | |
| Pathway | WP_PRADERWILLI_AND_ANGELMAN_SYNDROME | 9.69e-06 | 109 | 64 | 6 | M39542 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 4.79e-05 | 16 | 64 | 3 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 5.80e-05 | 17 | 64 | 3 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.48e-04 | 23 | 64 | 3 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 2.15e-04 | 26 | 64 | 3 | M27483 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 3.32e-04 | 73 | 64 | 4 | MM16641 | |
| Pathway | REACTOME_SEROTONIN_RECEPTORS | 1.09e-03 | 11 | 64 | 2 | MM15008 | |
| Pathway | REACTOME_SEROTONIN_RECEPTORS | 1.30e-03 | 12 | 64 | 2 | M6034 | |
| Pubmed | GABRB1 GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 2.97e-25 | 18 | 85 | 11 | 19078961 | |
| Pubmed | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GRM8 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 1.39e-20 | 81 | 85 | 13 | 22723691 | |
| Pubmed | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRA1 GABRA2 GABRA3 GABRA4 | 9.60e-20 | 18 | 85 | 9 | 18985723 | |
| Pubmed | Functional modifications of acid-sensing ion channels by ligand-gated chloride channels. | 4.82e-17 | 10 | 85 | 7 | 21789198 | |
| Pubmed | 4.82e-17 | 10 | 85 | 7 | 20583128 | ||
| Pubmed | 4.96e-15 | 8 | 85 | 6 | 8175718 | ||
| Pubmed | GABRD GABRG1 GABRG2 GABRG3 GABRR2 HTR1F HTR2B CNTN5 SLC1A1 GABRA1 GABRA2 GABRR3 GABRA3 GABRA6 | 2.05e-14 | 300 | 85 | 14 | 19086053 | |
| Pubmed | 4.58e-14 | 21 | 85 | 7 | 25708312 | ||
| Pubmed | Region and layer-specific expression of GABAA receptor isoforms and KCC2 in developing cortex. | 8.14e-14 | 11 | 85 | 6 | 38894703 | |
| Pubmed | 3.01e-13 | 13 | 85 | 6 | 22569571 | ||
| Pubmed | 3.01e-13 | 13 | 85 | 6 | 22640814 | ||
| Pubmed | 4.63e-13 | 6 | 85 | 5 | 20457185 | ||
| Pubmed | 5.26e-13 | 14 | 85 | 6 | 22768092 | ||
| Pubmed | Association study of 182 candidate genes in anorexia nervosa. | GABRB1 GABRG1 GABRG2 GABRG3 GABRR2 SLC1A1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 9.06e-13 | 182 | 85 | 11 | 20468064 |
| Pubmed | 1.62e-12 | 7 | 85 | 5 | 7560270 | ||
| Pubmed | 1.62e-12 | 7 | 85 | 5 | 16080114 | ||
| Pubmed | theta, a novel gamma-aminobutyric acid type A receptor subunit. | 1.62e-12 | 7 | 85 | 5 | 10449790 | |
| Pubmed | 4.31e-12 | 8 | 85 | 5 | 11528422 | ||
| Pubmed | Association study between GABA receptor genes and anxiety spectrum disorders. | 3.32e-11 | 4 | 85 | 4 | 19842164 | |
| Pubmed | 3.32e-11 | 4 | 85 | 4 | 25080596 | ||
| Pubmed | 3.32e-11 | 4 | 85 | 4 | 26518133 | ||
| Pubmed | Genetical genomic determinants of alcohol consumption in rats and humans. | GABRB1 GABRD GABRG2 GABRG3 HTR2B GABRA2 GABRA3 GABRA4 GABRA6 | 3.49e-11 | 130 | 85 | 9 | 19874574 |
| Pubmed | 3.53e-11 | 11 | 85 | 5 | 39137998 | ||
| Pubmed | Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. | 3.53e-11 | 11 | 85 | 5 | 9924185 | |
| Pubmed | 4.96e-10 | 6 | 85 | 4 | 21751815 | ||
| Pubmed | 4.96e-10 | 6 | 85 | 4 | 20412381 | ||
| Pubmed | Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. | 4.96e-10 | 6 | 85 | 4 | 15033447 | |
| Pubmed | 1.16e-09 | 7 | 85 | 4 | 16101898 | ||
| Pubmed | Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. | 1.16e-09 | 7 | 85 | 4 | 20843900 | |
| Pubmed | 1.16e-09 | 7 | 85 | 4 | 17021187 | ||
| Pubmed | 4.15e-09 | 9 | 85 | 4 | 21464123 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | EYS SHANK2 INCENP FAM186A SHC1 MUC16 BTAF1 FGFR2 ELP4 GABRA3 LRP8 | 6.70e-09 | 420 | 85 | 11 | 28065597 |
| Pubmed | 1.08e-08 | 11 | 85 | 4 | 17698926 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 11136737 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 16835366 | ||
| Pubmed | Investigation of autism and GABA receptor subunit genes in multiple ethnic groups. | 1.41e-08 | 3 | 85 | 3 | 16770606 | |
| Pubmed | GABRG1 and GABRA2 as independent predictors for alcoholism in two populations. | 1.41e-08 | 3 | 85 | 3 | 18818659 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 1359369 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 15304513 | ||
| Pubmed | Spatiotemporal specificity of GABAA receptor-mediated regulation of adult hippocampal neurogenesis. | 1.41e-08 | 3 | 85 | 3 | 21722213 | |
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 19019179 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 10512748 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 29023704 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 1356407 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 28816653 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 24027285 | ||
| Pubmed | 1.41e-08 | 3 | 85 | 3 | 15017002 | ||
| Pubmed | Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology. | 1.41e-08 | 3 | 85 | 3 | 2538761 | |
| Pubmed | Chromosomal localization of GABAA receptor subunit genes: relationship to human genetic disease. | 1.62e-08 | 12 | 85 | 4 | 2561974 | |
| Pubmed | Gephyrin plays a key role in BDNF-dependent regulation of amygdala surface GABAARs. | 5.63e-08 | 4 | 85 | 3 | 24096136 | |
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 25865415 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 12232773 | ||
| Pubmed | Identification of multiple genetic loci linked to the propensity for "behavioral despair" in mice. | 5.63e-08 | 4 | 85 | 3 | 11875023 | |
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 11948245 | ||
| Pubmed | Prostaglandin E2 attenuates preoptic expression of GABAA receptors via EP3 receptors. | 5.63e-08 | 4 | 85 | 3 | 18292084 | |
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 14715953 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 17440936 | ||
| Pubmed | GABA(A) receptor downregulation in brains of subjects with autism. | 5.63e-08 | 4 | 85 | 3 | 18821008 | |
| Pubmed | 8.76e-08 | 45 | 85 | 5 | 25979088 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 12574411 | ||
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 7643102 | ||
| Pubmed | Fine mapping of a sedative-hypnotic drug withdrawal locus on mouse chromosome 11. | 1.40e-07 | 5 | 85 | 3 | 16436183 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 27129275 | ||
| Pubmed | Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia. | 1.40e-07 | 5 | 85 | 3 | 16172613 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 28978485 | ||
| Pubmed | Insensitivity to anaesthetic agents conferred by a class of GABA(A) receptor subunit. | 1.40e-07 | 5 | 85 | 3 | 9039914 | |
| Pubmed | GABAA receptors: structure, function, pharmacology, and related disorders. | 1.40e-07 | 5 | 85 | 3 | 34417930 | |
| Pubmed | Itch suppression in mice and dogs by modulation of spinal α2 and α3GABAA receptors. | 1.40e-07 | 5 | 85 | 3 | 30104684 | |
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 10447508 | ||
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 9682826 | ||
| Pubmed | Evolution of GABA(A) receptor diversity in the human genome. | 2.80e-07 | 6 | 85 | 3 | 10023064 | |
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 11331379 | ||
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 1315307 | ||
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 35228700 | ||
| Pubmed | 5.71e-07 | 197 | 85 | 7 | 36604605 | ||
| Pubmed | 7.82e-07 | 8 | 85 | 3 | 18334916 | ||
| Pubmed | Association studies of neurotransmitter gene polymorphisms in alcoholic Caucasians. | 7.82e-07 | 8 | 85 | 3 | 15542698 | |
| Pubmed | Histone H2AX-dependent GABA(A) receptor regulation of stem cell proliferation. | 7.82e-07 | 8 | 85 | 3 | 18185516 | |
| Pubmed | 9.94e-07 | 31 | 85 | 4 | 19736351 | ||
| Pubmed | 1.67e-06 | 10 | 85 | 3 | 36733270 | ||
| Pubmed | Genetic mapping of three GABAA receptor-subunit genes in the mouse. | 3.05e-06 | 12 | 85 | 3 | 8390964 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 24431441 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 19289452 | ||
| Pubmed | Mutation screen of GABRA1, GABRB2 and GABRG2 genes in Japanese patients with absence seizures. | 5.90e-06 | 2 | 85 | 2 | 15955415 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 25348603 | ||
| Pubmed | A critical role for alpha4betadelta GABAA receptors in shaping learning deficits at puberty in mice. | 5.90e-06 | 2 | 85 | 2 | 20299596 | |
| Pubmed | Postsynaptic clustering of gamma-aminobutyric acid type A receptors by the gamma3 subunit in vivo. | 5.90e-06 | 2 | 85 | 2 | 10536013 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22763624 | ||
| Pubmed | Cytoskeleton integrity influences XRCC1 and PCNA dynamics at DNA damage. | 5.90e-06 | 2 | 85 | 2 | 34379448 | |
| Pubmed | Novel α1 and γ2 GABAA receptor subunit mutations in families with idiopathic generalized epilepsy. | 5.90e-06 | 2 | 85 | 2 | 21714819 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 16412095 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 31150793 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 14766194 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 15610161 | ||
| Pubmed | Molecular and neuronal substrate for the selective attenuation of anxiety. | 5.90e-06 | 2 | 85 | 2 | 11021797 | |
| Pubmed | Gender-specific contribution of the GABA(A) subunit genes on 5q33 in methamphetamine use disorder. | 5.90e-06 | 2 | 85 | 2 | 14569258 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12958310 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 18085262 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 17976953 | ||
| Pubmed | GABA(A)R plasticity during pregnancy: relevance to postpartum depression. | 5.90e-06 | 2 | 85 | 2 | 18667149 | |
| Interaction | GABRG1 interactions | 7.98e-09 | 7 | 80 | 4 | int:GABRG1 | |
| Interaction | GABRG2 interactions | 2.21e-07 | 34 | 80 | 5 | int:GABRG2 | |
| Interaction | GABRA1 interactions | 2.42e-06 | 152 | 80 | 7 | int:GABRA1 | |
| Interaction | DLG4 interactions | GABRB1 GABRG1 GABRG2 SHANK2 FASTKD1 SLC1A1 GABRA1 GABRA2 GABRA3 LRP8 | 1.11e-05 | 449 | 80 | 10 | int:DLG4 |
| Cytoband | 4p12 | 5.18e-08 | 20 | 85 | 4 | 4p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p12 | 1.59e-07 | 26 | 85 | 4 | chr4p12 | |
| Cytoband | 5q34 | 2.92e-05 | 32 | 85 | 3 | 5q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q34 | 6.21e-05 | 41 | 85 | 3 | chr5q34 | |
| Cytoband | 3q13.2 | 1.52e-03 | 31 | 85 | 2 | 3q13.2 | |
| Cytoband | 7q22 | 2.28e-03 | 38 | 85 | 2 | 7q22 | |
| Cytoband | 11q13.2 | 3.47e-03 | 47 | 85 | 2 | 11q13.2 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 6.40e-26 | 19 | 64 | 12 | 563 |
| GeneFamily | CD molecules|Mucins | 8.17e-07 | 21 | 64 | 4 | 648 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.45e-04 | 29 | 64 | 3 | 396 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 9.38e-04 | 13 | 64 | 2 | 170 | |
| GeneFamily | Fibronectin type III domain containing | 2.48e-03 | 160 | 64 | 4 | 555 | |
| GeneFamily | Basic helix-loop-helix proteins | 6.97e-03 | 110 | 64 | 3 | 420 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | GABRD GABRG1 GABRG2 GABRG3 GABRR2 HTR1F VEZF1 PTPRQ KCNQ3 GRM8 PCSK4 PADI2 SLC1A1 TNXB GABRR3 GABRA3 GABRA6 | 4.45e-07 | 1281 | 83 | 17 | M1884 |
| CoexpressionAtlas | BM Top 100 - occipital lobe | 7.73e-06 | 73 | 79 | 5 | BM Top 100 - occipital lobe | |
| CoexpressionAtlas | BM Top 100 - temporal lobe | 8.26e-06 | 74 | 79 | 5 | BM Top 100 - temporal lobe | |
| CoexpressionAtlas | cerebral cortex | GABRB1 GABRD GABRG1 GABRG2 DOK6 SHANK2 CNTN5 KCNQ3 GRM8 WASF1 PADI2 GABRA1 GABRA2 GABRA3 LRP8 GABRA4 | 6.11e-05 | 1428 | 79 | 16 | cerebral cortex |
| CoexpressionAtlas | BM Top 100 - cerebellum | 1.21e-04 | 68 | 79 | 4 | BM Top 100 - cerebellum | |
| CoexpressionAtlas | BM Top 100 - cerebral cortex | 1.51e-04 | 72 | 79 | 4 | BM Top 100 - cerebral cortex | |
| CoexpressionAtlas | BM Top 100 - frontal lobe | 1.51e-04 | 72 | 79 | 4 | BM Top 100 - frontal lobe | |
| CoexpressionAtlas | BM Top 100 - amygdala | 1.59e-04 | 73 | 79 | 4 | BM Top 100 - amygdala | |
| CoexpressionAtlas | BM Top 100 - parietal lobe | 1.76e-04 | 75 | 79 | 4 | BM Top 100 - parietal lobe | |
| CoexpressionAtlas | BM Top 100 - accumbens | 2.05e-04 | 78 | 79 | 4 | BM Top 100 - accumbens | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.77e-09 | 189 | 84 | 8 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.86e-08 | 188 | 84 | 7 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.38e-08 | 190 | 84 | 7 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.38e-08 | 190 | 84 | 7 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.38e-08 | 190 | 84 | 7 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.21e-08 | 193 | 84 | 7 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 9.12e-08 | 196 | 84 | 7 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 9.12e-08 | 196 | 84 | 7 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-07 | 200 | 84 | 7 | 2f481e2fd248c02a5aa2e0248c16808df142fed2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-07 | 200 | 84 | 7 | bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-07 | 200 | 84 | 7 | dc674124475edf83908b51a4e1454bc2dc4f06fa | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-06 | 179 | 84 | 6 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-06 | 183 | 84 | 6 | 25c96df8ea0c7bbedbb7699ee84ad6234d19cba8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-06 | 183 | 84 | 6 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-06 | 183 | 84 | 6 | 99bb4ceb92f6467f2359a42ab2cff6df18825a30 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-06 | 184 | 84 | 6 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 185 | 84 | 6 | dbbd348714cd16a4948a04648e914b1e71e2a8ef | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 185 | 84 | 6 | bea69058afa5aa927fe15c1f8d46460562ec4dd4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-06 | 185 | 84 | 6 | e87e6e097dc29ece8aea671935bde281b99b93ea | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-06 | 186 | 84 | 6 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-06 | 186 | 84 | 6 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-06 | 187 | 84 | 6 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-06 | 189 | 84 | 6 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-06 | 190 | 84 | 6 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-06 | 190 | 84 | 6 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-06 | 190 | 84 | 6 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-06 | 190 | 84 | 6 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-06 | 193 | 84 | 6 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-06 | 193 | 84 | 6 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-06 | 193 | 84 | 6 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-06 | 194 | 84 | 6 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-06 | 196 | 84 | 6 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.06e-06 | 198 | 84 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.06e-06 | 198 | 84 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 2.12e-06 | 199 | 84 | 6 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.18e-06 | 200 | 84 | 6 | c65e6336725856c4b5f6aeba1cf86a23ec815d34 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.18e-06 | 200 | 84 | 6 | 117a25b3b9cdbc2e198381350a8362bee25e82e7 | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.18e-06 | 200 | 84 | 6 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.18e-06 | 200 | 84 | 6 | d459e51507bf26865e6e7e04411379ec82a3edf8 | |
| ToppCell | COVID-19-Fibroblasts-Mesothelial_FB|COVID-19 / group, cell type (main and fine annotations) | 7.12e-06 | 141 | 84 | 5 | 7e6dcccb74e7ee90b69dc91b59491b84f3a713c9 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.01e-06 | 148 | 84 | 5 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-05 | 170 | 84 | 5 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.86e-05 | 172 | 84 | 5 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.08e-05 | 176 | 84 | 5 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-05 | 177 | 84 | 5 | 91706bd0d4dda8d98843fb00b898d5aca4d66b64 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.14e-05 | 177 | 84 | 5 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.32e-05 | 180 | 84 | 5 | 8f774dcacc1626e4e6492f1eb927b0ed56fbe686 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.32e-05 | 180 | 84 | 5 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-05 | 181 | 84 | 5 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 182 | 84 | 5 | d41ff834b8fc1d0e23cac7ae261de5f72874e462 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 182 | 84 | 5 | 6cde859edfe7607bd7ada89d20258413d06f4207 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-05 | 182 | 84 | 5 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.57e-05 | 184 | 84 | 5 | c4c1a3d279ca733b865ce46570d7642dc137f9a4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.64e-05 | 185 | 84 | 5 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.71e-05 | 186 | 84 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-05 | 187 | 84 | 5 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.78e-05 | 187 | 84 | 5 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.85e-05 | 188 | 84 | 5 | 72cbfe9dc0583dbeafa6cb0945fa370d0c808284 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.93e-05 | 189 | 84 | 5 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.00e-05 | 190 | 84 | 5 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.00e-05 | 190 | 84 | 5 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.00e-05 | 190 | 84 | 5 | b4088128f5acf53f43244c9af9fe44e033f1a57a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.08e-05 | 191 | 84 | 5 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.08e-05 | 191 | 84 | 5 | 782bc7946417549ffd39e5b596db659436fa01ba | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.16e-05 | 192 | 84 | 5 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 3.16e-05 | 192 | 84 | 5 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.16e-05 | 192 | 84 | 5 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.23e-05 | 193 | 84 | 5 | 826457e2aafdb61ead8a0a44d8cf9088d310684b | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.23e-05 | 193 | 84 | 5 | af6ec2c2ba92aef3e41531c3c7215b3300437bd9 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 3.32e-05 | 194 | 84 | 5 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 3.32e-05 | 194 | 84 | 5 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-05 | 194 | 84 | 5 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.32e-05 | 194 | 84 | 5 | b19e16a76d7342ff9a665d19c9151652916f17d4 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.43e-05 | 97 | 84 | 4 | d93193cc8455373467a9e63d8b883c3139773a03 | |
| ToppCell | Substantia_nigra-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.43e-05 | 97 | 84 | 4 | 1dc648eb31b41419fbd859e9fab4a32ed4226a97 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.65e-05 | 198 | 84 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.65e-05 | 198 | 84 | 5 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-MEPE-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | d4161fcbbe47236aac4a077c0994887e765b0b47 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | 1b485ff2435c6732be58cbc9eb2f5c273f9c4bf2 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | 5ec469267747dce3601c1d8ad01af89fa5b29acc | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.83e-05 | 200 | 84 | 5 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-MEPE|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | 0d0c69758370d3c44ffe6640e332b6118fc5ce58 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.83e-05 | 200 | 84 | 5 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-MEPE--L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | c546fa80876640bd57a5252df611977009bef9e8 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | e79d93d55b25804f2608185168da472301b6ebca | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.83e-05 | 200 | 84 | 5 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.83e-05 | 200 | 84 | 5 | 320d5a3a1e7da2fa8f1a164e29e180ec8ac9889c | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.23e-05 | 108 | 84 | 4 | c647f6595e7cccea91429a2377c9de6cc1acff4d | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Satb1_(Substantia_Innominata_(SI))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.84e-05 | 42 | 84 | 3 | f4ce47a88935f1eaa9395791294ae567aac92545 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Satb1_(Substantia_Innominata_(SI))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.84e-05 | 42 | 84 | 3 | 14eda1c244cf32cade59fd2f57dd9bc00c97c895 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Satb1_(Substantia_Innominata_(SI))--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.84e-05 | 42 | 84 | 3 | f02985b8cdbd858c362766953a8f08ce338e8ce7 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Serpinf1-Serpinf1_Clrn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.38e-05 | 118 | 84 | 4 | 702548d8187d54e8814375e5ae7609631fc71d5f | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 1.39e-04 | 139 | 84 | 4 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-2|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.47e-04 | 141 | 84 | 4 | 1baa054c2ae3b446d1954244b7fbf8af824ef345 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.51e-04 | 142 | 84 | 4 | 191a13bba143ecdfc2bfd797c3ac191481388298 | |
| Computational | Neurotransmitter (GABA) receptor. | 4.16e-09 | 15 | 48 | 5 | MODULE_215 | |
| Computational | Genes in the cancer module 396. | 1.69e-07 | 12 | 48 | 4 | MODULE_396 | |
| Computational | Genes in the cancer module 141. | 6.12e-07 | 16 | 48 | 4 | MODULE_141 | |
| Computational | Ion channels. | 5.70e-06 | 27 | 48 | 4 | MODULE_214 | |
| Computational | Ion channels. | 1.40e-05 | 70 | 48 | 5 | MODULE_316 | |
| Computational | Vesicular transport / synapse genes. | 3.02e-05 | 82 | 48 | 5 | MODULE_274 | |
| Computational | Porins / transporters. | 3.78e-05 | 211 | 48 | 7 | MODULE_63 | |
| Computational | Genes in the cancer module 289. | 2.17e-04 | 124 | 48 | 5 | MODULE_289 | |
| Computational | GPCR signaling pathways (immune and neuro). | 6.75e-04 | 90 | 48 | 4 | MODULE_375 | |
| Drug | dihydroxyaflavinine | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 4.50e-21 | 17 | 83 | 10 | CID000156857 |
| Drug | CGS 8216 | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 1.38e-19 | 33 | 83 | 11 | CID000104916 |
| Drug | AC1L2FYN | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 1.38e-19 | 33 | 83 | 11 | CID000071333 |
| Drug | flurazepam | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 2.95e-19 | 35 | 83 | 11 | CID000003393 |
| Drug | methohexital | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 4.45e-19 | 24 | 83 | 10 | CID000009034 |
| Drug | secobarbital | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 6.01e-19 | 37 | 83 | 11 | CID000005193 |
| Drug | triazolam | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 ABCB5 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 7.29e-19 | 54 | 83 | 12 | CID000005556 |
| Drug | DMCM | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 8.43e-19 | 38 | 83 | 11 | CID000104999 |
| Drug | zaleplon | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 1.17e-18 | 39 | 83 | 11 | CID000005719 |
| Drug | Gabrene | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 1.61e-18 | 40 | 83 | 11 | CID005361323 |
| Drug | gaboxadol | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 2.19e-18 | 41 | 83 | 11 | CID000003448 |
| Drug | 5 beta-alphaxalone | GABRB1 GABRD GABRG1 GABRG2 GABRG3 SLC1A1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 2.96e-18 | 42 | 83 | 11 | CID000068930 |
| Drug | zolpidem | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 3.97e-18 | 43 | 83 | 11 | CID000005732 |
| Drug | AC1Q5UBL | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 HTR1F HTR2B GRM8 SLC1A1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 5.12e-18 | 146 | 83 | 15 | CID000005466 |
| Drug | lorazepam | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 5.28e-18 | 44 | 83 | 11 | CID000003958 |
| Drug | 3-isothujone | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 6.70e-18 | 30 | 83 | 10 | CID000011027 |
| Drug | heptachlor epoxide | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 9.13e-18 | 46 | 83 | 11 | CID000013930 |
| Drug | vigabatrin | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 1.98e-17 | 49 | 83 | 11 | CID000005665 |
| Drug | felbamate | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GRM8 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 2.16e-17 | 70 | 83 | 12 | CID000003331 |
| Drug | alpha IMGBL | 2.80e-17 | 13 | 83 | 8 | CID000131516 | |
| Drug | acamprosate | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GRM8 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 4.40e-17 | 74 | 83 | 12 | CID000071158 |
| Drug | cyclothiazide | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GRM8 SLC1A1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 6.19e-17 | 103 | 83 | 13 | CID000002910 |
| Drug | clonazepam | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 KCNQ3 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 1.62e-16 | 82 | 83 | 12 | CID000002802 |
| Drug | flunitrazepam | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 1.84e-16 | 59 | 83 | 11 | CID000003380 |
| Drug | chlordiazepoxide | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 HTR2B WASF1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 2.43e-16 | 114 | 83 | 13 | CID000002712 |
| Drug | beta-carboline | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 4.83e-16 | 64 | 83 | 11 | CID000064961 |
| Drug | picrotoxinine | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 5.80e-16 | 65 | 83 | 11 | CID000004816 |
| Drug | thymol | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 8.67e-16 | 46 | 83 | 10 | CID000006989 |
| Drug | clorazepate | 9.37e-16 | 18 | 83 | 8 | CID000002809 | |
| Drug | ZK 93426 | 1.61e-15 | 19 | 83 | 8 | CID000115210 | |
| Drug | etomidate | GABRB1 GABRD GABRG1 GABRG2 GABRG3 SLC1A1 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 1.63e-15 | 71 | 83 | 11 | CID000036339 |
| Drug | fosazepam | 2.15e-15 | 11 | 83 | 7 | CID000037114 | |
| Drug | C19H18ClN3O | 2.15e-15 | 11 | 83 | 7 | CID000027452 | |
| Drug | flutoprazepam | 2.15e-15 | 11 | 83 | 7 | CID000003400 | |
| Drug | Arfendazam | 2.15e-15 | 11 | 83 | 7 | CID000065803 | |
| Drug | camazepam | 2.15e-15 | 11 | 83 | 7 | CID000037367 | |
| Drug | triflubazam | 2.15e-15 | 11 | 83 | 7 | CID000031157 | |
| Drug | Bu-1014 | 2.15e-15 | 11 | 83 | 7 | CID015942721 | |
| Drug | Zapizolam | 2.15e-15 | 11 | 83 | 7 | CID000068832 | |
| Drug | Reclazepam | 2.15e-15 | 11 | 83 | 7 | CID003052777 | |
| Drug | iclazepam | 2.15e-15 | 11 | 83 | 7 | CID000068777 | |
| Drug | menitrazepam | 2.15e-15 | 11 | 83 | 7 | CID000189875 | |
| Drug | Serin hydrazid | 2.15e-15 | 11 | 83 | 7 | CID000041637 | |
| Drug | sulazepam | 2.15e-15 | 11 | 83 | 7 | CID000017931 | |
| Drug | elfazepam | 2.15e-15 | 11 | 83 | 7 | CID000065445 | |
| Drug | uldazepam | 2.15e-15 | 11 | 83 | 7 | CID000034274 | |
| Drug | gidazepam | 2.15e-15 | 11 | 83 | 7 | CID000121919 | |
| Drug | fletazepam | 2.15e-15 | 11 | 83 | 7 | CID000036834 | |
| Drug | AC1N65YL | 2.68e-15 | 20 | 83 | 8 | CID004229818 | |
| Drug | EBOB | 2.68e-15 | 20 | 83 | 8 | CID000115223 | |
| Drug | prazepam | 4.32e-15 | 21 | 83 | 8 | CID000004890 | |
| Drug | bicuculline methochloride | 4.32e-15 | 21 | 83 | 8 | CID000123659 | |
| Drug | R 5135 | 4.32e-15 | 21 | 83 | 8 | CID000119544 | |
| Drug | midazolam | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 ABCB5 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 4.52e-15 | 107 | 83 | 12 | CID000004192 |
| Drug | SB-205384 | 5.15e-15 | 12 | 83 | 7 | CID000197690 | |
| Drug | U-93631 | 5.15e-15 | 12 | 83 | 7 | CID000197626 | |
| Drug | haloxazolam | 5.15e-15 | 12 | 83 | 7 | CID000003563 | |
| Drug | pivoxazepam | 5.15e-15 | 12 | 83 | 7 | CID000068722 | |
| Drug | doxefazepam | 5.15e-15 | 12 | 83 | 7 | CID000038668 | |
| Drug | razobazam | 5.15e-15 | 12 | 83 | 7 | CID000071228 | |
| Drug | FG 7142 | GABRG1 GABRG2 GABRG3 GABRR2 HTR2B GABRA1 GABRA2 GABRA4 GABRA6 | 6.32e-15 | 36 | 83 | 9 | CID000004375 |
| Drug | quazepam | 6.77e-15 | 22 | 83 | 8 | CID000004999 | |
| Drug | imidazenil | 6.77e-15 | 22 | 83 | 8 | CID000119194 | |
| Drug | adinazolam | 1.03e-14 | 23 | 83 | 8 | CID000037632 | |
| Drug | zolazepam | 1.03e-14 | 23 | 83 | 8 | CID000035775 | |
| Drug | AC1MVFYM | 1.11e-14 | 13 | 83 | 7 | CID003707225 | |
| Drug | nerisopam | 1.11e-14 | 13 | 83 | 7 | CID000065875 | |
| Drug | Ro 11-3128 | 1.11e-14 | 13 | 83 | 7 | CID000093364 | |
| Drug | cinolazepam | 1.11e-14 | 13 | 83 | 7 | CID003033621 | |
| Drug | flutazolam | 1.11e-14 | 13 | 83 | 7 | CID000003398 | |
| Drug | 4-PIOL | 1.11e-14 | 13 | 83 | 7 | CID000125520 | |
| Drug | metaclazepam | 1.11e-14 | 13 | 83 | 7 | CID000071272 | |
| Drug | AC1L1B1W | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 1.14e-14 | 84 | 83 | 11 | CID000001248 |
| Drug | 5 beta-pregnanediol | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 1.54e-14 | 60 | 83 | 10 | CID000012547 |
| Drug | gamma-acetylenic GABA | 1.55e-14 | 24 | 83 | 8 | CID000003452 | |
| Drug | medazepam | 1.55e-14 | 24 | 83 | 8 | CID000004041 | |
| Drug | SL 75102 | 1.55e-14 | 24 | 83 | 8 | CID005751746 | |
| Drug | neostigmine | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 1.70e-14 | 87 | 83 | 11 | CID000004456 |
| Drug | gamma-Aminobutyric Acid | GABRB1 GABRD GABRG1 GABRG2 GABRA1 GABRA2 GABRR3 GABRA3 GABRA4 GABRA6 | 2.18e-14 | 62 | 83 | 10 | ctd:D005680 |
| Drug | beta-CCt | 2.22e-14 | 14 | 83 | 7 | CID000124514 | |
| Drug | Me-lex | 2.22e-14 | 14 | 83 | 7 | CID000004177 | |
| Drug | ethyl loflazepate | 2.22e-14 | 14 | 83 | 7 | CID000003299 | |
| Drug | isonipecotic acid | 2.27e-14 | 25 | 83 | 8 | CID000003773 | |
| Drug | P4-s | 2.27e-14 | 25 | 83 | 8 | CID000004838 | |
| Drug | CCD 1042 | 2.27e-14 | 25 | 83 | 8 | CID000038022 | |
| Drug | beta-CCE | 2.27e-14 | 25 | 83 | 8 | CID000105078 | |
| Drug | CGP55845 | GABRG1 GABRG2 GABRG3 GABRR2 GRM8 GABRA1 GABRA2 GABRA4 GABRA6 | 2.32e-14 | 41 | 83 | 9 | CID000123885 |
| Drug | pregnanolone | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 2.51e-14 | 90 | 83 | 11 | CID000031402 |
| Drug | AOAA | GABRB1 GABRD GABRG1 GABRG2 GABRG3 GABRR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA6 | 2.84e-14 | 91 | 83 | 11 | CID000000285 |
| Drug | SKF97541 | 3.27e-14 | 26 | 83 | 8 | CID000005230 | |
| Drug | V-X-A | 3.27e-14 | 26 | 83 | 8 | CID006369389 | |
| Drug | SR 95103 | 4.15e-14 | 15 | 83 | 7 | CID000125958 | |
| Drug | loprazolam | 4.15e-14 | 15 | 83 | 7 | CID003033860 | |
| Drug | premazepam | 4.15e-14 | 15 | 83 | 7 | CID000072104 | |
| Drug | pinazepam | 4.15e-14 | 15 | 83 | 7 | CID000040391 | |
| Drug | fludiazepam | 4.15e-14 | 15 | 83 | 7 | CID000003369 | |
| Drug | TBOB | 4.15e-14 | 15 | 83 | 7 | CID000114986 | |
| Drug | girisopam | 4.15e-14 | 15 | 83 | 7 | CID000071257 | |
| Drug | NO-711 | GABRG1 GABRG2 GABRG3 GABRR2 GRM8 SLC1A1 GABRA1 GABRA2 GABRA4 GABRA6 | 4.23e-14 | 66 | 83 | 10 | CID000004515 |
| Drug | pitrazepin | 4.63e-14 | 27 | 83 | 8 | CID000146222 | |
| Disease | autistic disorder (is_implicated_in) | 2.46e-11 | 42 | 82 | 7 | DOID:12849 (is_implicated_in) | |
| Disease | Alcoholic Intoxication, Chronic | GABRB1 GABRG1 GABRG2 GABRG3 GABRR2 GRM8 GABRA1 GABRA2 LRP8 GABRA6 | 3.89e-09 | 268 | 82 | 10 | C0001973 |
| Disease | Schizophrenia | GABRB1 GABRD GABRG2 HTR1F KCNQ3 FGFR2 XRCC1 CMYA5 GRM8 SLC1A1 TNXB GABRA1 LRP8 GABRA4 GABRA6 | 1.89e-08 | 883 | 82 | 15 | C0036341 |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.54e-07 | 49 | 82 | 5 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 6.82e-07 | 261 | 82 | 8 | C0004352 | |
| Disease | Juvenile Myoclonic Epilepsy | 1.15e-06 | 8 | 82 | 3 | C0270853 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.29e-06 | 152 | 82 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Hepatic Encephalopathy | 5.80e-06 | 13 | 82 | 3 | C0019151 | |
| Disease | Hepatic Coma | 5.80e-06 | 13 | 82 | 3 | C0019147 | |
| Disease | Fulminant Hepatic Failure with Cerebral Edema | 5.80e-06 | 13 | 82 | 3 | C0751197 | |
| Disease | Hepatic Stupor | 5.80e-06 | 13 | 82 | 3 | C0751198 | |
| Disease | Bipolar Disorder | GABRB1 GABRG1 GABRR2 SHANK2 KCNQ3 FGFR2 SLC1A1 GABRA1 GABRA3 | 7.21e-06 | 477 | 82 | 9 | C0005586 |
| Disease | Schizoaffective disorder, bipolar type | 7.63e-06 | 2 | 82 | 2 | C0270496 | |
| Disease | hepatic encephalopathy (biomarker_via_orthology) | 9.19e-06 | 15 | 82 | 3 | DOID:13413 (biomarker_via_orthology) | |
| Disease | EPILEPSY, CHILDHOOD ABSENCE, 1 | 1.14e-04 | 6 | 82 | 2 | C1838604 | |
| Disease | colorectal adenocarcinoma (is_implicated_in) | 1.27e-04 | 35 | 82 | 3 | DOID:0050861 (is_implicated_in) | |
| Disease | Albinism, Oculocutaneous | 1.59e-04 | 7 | 82 | 2 | C0078918 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 2.11e-04 | 8 | 82 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 2.50e-04 | 447 | 82 | 7 | C3714756 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 2.71e-04 | 9 | 82 | 2 | C3502809 | |
| Disease | Prostatic Neoplasms | 3.17e-04 | 616 | 82 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.17e-04 | 616 | 82 | 8 | C0376358 | |
| Disease | stomach carcinoma (is_implicated_in) | 4.94e-04 | 12 | 82 | 2 | DOID:5517 (is_implicated_in) | |
| Disease | autistic disorder (is_marker_for) | 4.94e-04 | 12 | 82 | 2 | DOID:12849 (is_marker_for) | |
| Disease | Infantile Severe Myoclonic Epilepsy | 5.83e-04 | 13 | 82 | 2 | C0751122 | |
| Disease | Alcohol abuse | 8.72e-04 | 67 | 82 | 3 | C0085762 | |
| Disease | Tremor, Rubral | 8.93e-04 | 16 | 82 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 8.93e-04 | 16 | 82 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 8.93e-04 | 16 | 82 | 2 | C0278161 | |
| Disease | Abnormal coordination | 8.93e-04 | 16 | 82 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 8.93e-04 | 16 | 82 | 2 | C0427190 | |
| Disease | Ataxia, Sensory | 8.93e-04 | 16 | 82 | 2 | C0240991 | |
| Disease | epilepsy (implicated_via_orthology) | 1.12e-03 | 163 | 82 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | diffuse plaque measurement | 1.22e-03 | 758 | 82 | 8 | EFO_0010699 | |
| Disease | risk-taking behaviour | 1.29e-03 | 764 | 82 | 8 | EFO_0008579 | |
| Disease | cortisol measurement | 1.40e-03 | 20 | 82 | 2 | EFO_0005843 | |
| Disease | sensory perception of sweet taste | 1.56e-03 | 82 | 82 | 3 | GO_0050916 | |
| Disease | progression free survival, ovarian serous carcinoma | 1.70e-03 | 22 | 82 | 2 | EFO_0004920, EFO_1001516 | |
| Disease | influenza A (H1N1) | 1.85e-03 | 87 | 82 | 3 | EFO_1001488 | |
| Disease | Attention deficit hyperactivity disorder | 2.02e-03 | 24 | 82 | 2 | C1263846 | |
| Disease | eye color | 2.04e-03 | 90 | 82 | 3 | EFO_0003949 | |
| Disease | Ataxia | 2.20e-03 | 25 | 82 | 2 | C0004134 | |
| Disease | Neurodevelopmental Disorders | 2.24e-03 | 93 | 82 | 3 | C1535926 | |
| Disease | uterine fibroid | 2.33e-03 | 199 | 82 | 4 | EFO_0000731 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 2.56e-03 | 27 | 82 | 2 | DOID:10584 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MRLRSSTIQSSSIIL | 446 | P41595 | |
| AFLTTSRTPLLSMST | 1451 | Q9NR48 | |
| MITLSFRTTRTPSLL | 1041 | Q9BZ76 | |
| VSLTLSGLALMTTTI | 26 | P30939 | |
| LTTLPSATMSTILTR | 2056 | Q8IZF6 | |
| SATMSTILTRTIPTP | 2061 | Q8IZF6 | |
| LTLVTLSTSPLIMAS | 206 | Q2M3G0 | |
| ISSPLTKSISLMTIS | 1681 | Q12802 | |
| SLTATILTMSSSRLP | 126 | Q7RTS1 | |
| STSSSSVTLLLALMI | 1081 | O94779 | |
| MSRLLSTKPSSIIST | 271 | Q8NCD3 | |
| TSTSDMLLKLARTTP | 141 | Q9NW64 | |
| RITTRLSSTADTPML | 446 | P21802 | |
| MTSLLTPSLVMTTDT | 6831 | Q8WXI7 | |
| QSTVLPEISTRTMTR | 7001 | Q8WXI7 | |
| ETITRLPTSSIMTES | 8181 | Q8WXI7 | |
| EAITRLSTSPIMTES | 8476 | Q8WXI7 | |
| TRLSTSPIMTESAEI | 9646 | Q8WXI7 | |
| SPAVSRLVTSMVTSL | 10786 | Q8WXI7 | |
| RAVTSTTIPILTLSS | 11106 | Q8WXI7 | |
| MIPTSTLSLGLLETT | 11861 | Q8WXI7 | |
| SVRSRPTSMTLTTSL | 211 | C9J442 | |
| SSLTFMSTSARTRPL | 551 | A0AUZ9 | |
| MAVVVRSPLRTSLSS | 151 | Q9BR39 | |
| ALSIQTSSSMSVIRP | 1801 | Q5T1H1 | |
| RPLLSKTMTSTEQSL | 1296 | Q4ZG55 | |
| RILESITVSSLMATP | 226 | Q9NQS7 | |
| SITRDSDTPLSLMSV | 781 | O43525 | |
| MATVIRSPLRTSLAS | 151 | Q9HDC5 | |
| LTMTTLSISARNSLP | 291 | P47869 | |
| LLISIIIMVSASSSS | 6 | Q6Q8B3 | |
| LEISLTSPMGTRSTL | 506 | Q6UW60 | |
| LSSTVTLSMSADVPL | 221 | P12004 | |
| CISVTVPSMLSRLLS | 76 | P47881 | |
| LIVLTVMTSRSLGSP | 36 | Q8NGF9 | |
| LVSMTSATTPSLRPT | 1251 | Q02505 | |
| LTMTTLSISARNSLP | 316 | P34903 | |
| LTMTTLSISARNSLP | 291 | P14867 | |
| VLTMTTLSISARHSL | 296 | P48169 | |
| GITTVLTMTTLSISA | 276 | Q16445 | |
| LTMTTLSISARHSLP | 281 | Q16445 | |
| TTVLTMTTISTHLRE | 281 | P18505 | |
| TTLMVSARSSLPRAS | 291 | O14764 | |
| LSPSTTLRVTMSQAS | 71 | Q9Y2J8 | |
| TTLTVSMSLSASVSL | 816 | O00222 | |
| TGKLLVTSTTITIRM | 1801 | Q9UMZ3 | |
| MTTAILERLSTLSVS | 1 | Q8TEZ7 | |
| SLGITTVLTMSTIIT | 301 | A8MPY1 | |
| LTASTNSIMTLLSSL | 486 | O14981 | |
| RLQTSLTEPMTLSKS | 246 | Q6PKX4 | |
| ARTSLGITTVLTMTT | 301 | Q8N1C3 | |
| GITTVLTMTTLSTIA | 306 | Q8N1C3 | |
| LTMTTLSTIARKSLP | 311 | Q8N1C3 | |
| TALGITTVLTMTTLS | 286 | Q99928 | |
| MTTLSTIARKSLPRV | 296 | Q99928 | |
| LTVTTGMTTTLLQPI | 536 | Q6P1L5 | |
| SSTMPAISELSSLLR | 1691 | Q8N3K9 | |
| SSLSVLMVNISSLIS | 191 | Q53R41 | |
| VPARTSLGITTVLTM | 301 | P18507 | |
| SLGITTVLTMTTLST | 306 | P18507 | |
| SSLMLLTQRVTSLSL | 121 | Q96T53 | |
| RVILSSSTSCLMPSK | 116 | Q9Y2S2 | |
| MSTTEIISPTRSLDR | 191 | Q6QHK4 | |
| LLRTSLSACIITMPT | 291 | Q96EB1 | |
| ISSTIVNLSTALSML | 261 | A6NE01 | |
| QLSTLLAPVIISSMT | 46 | Q92902 | |
| TALMISSSSATLPVT | 326 | P43005 | |
| MITLSFRTTRTPSLL | 1041 | Q96NU0 | |
| PARVSLGITTVLTMT | 291 | P28476 | |
| LASTMTRTVPATTRA | 746 | Q14114 | |
| LSDTCLSTSITPRMI | 66 | Q8NGL9 | |
| MLIVVTITSSPTLAS | 41 | Q8NH37 | |
| MSTLSITPVDTSTLV | 351 | Q685J3 | |
| VSTSLTSILVSTMPV | 2631 | Q685J3 | |
| MSTTSERSTLLTTVL | 3806 | Q685J3 | |
| TTSPTMSTVRATLRS | 456 | Q9H195 | |
| HTLTPSTALSKIMST | 526 | Q9H195 | |
| SLPATLSRSELMSVT | 216 | Q9NQ88 | |
| LVLILTTATLSSSMK | 241 | Q6ZW05 | |
| SLMFSPVTSLTTASR | 886 | Q9C0A6 | |
| ILLSTMVTSITGLST | 216 | Q13621 | |
| TMTTLTLTSLIPPIL | 6 | P03915 | |
| GLLKTMPLTSTSLTI | 361 | P03915 | |
| SLDPTITRSSMLSLI | 316 | Q96PQ1 | |
| PTTALTLRSKSMTSE | 741 | Q9UPX8 | |
| TSRILLSSMPSASKT | 871 | Q14246 | |
| RSTLMSSPRSLLCSI | 36 | Q8NBR9 | |
| MTALTVRRSEPSLST | 396 | Q6UXD7 | |
| VTITSPLSMTSPLTL | 446 | Q14119 | |
| PPISSSSMTSRILLR | 46 | O75030 | |
| VLTVTDTTPDSMRLS | 3561 | P22105 | |
| SSLTRTPSMASLTRT | 406 | Q9UF83 | |
| ASLTRTPSMVSLKRS | 451 | Q9UF83 | |
| SRASLTMTPSRASLT | 476 | Q9UF83 | |
| TASLTRMPSTASLTR | 531 | Q9UF83 | |
| LASVSTPLLSSMESV | 1196 | O60281 | |
| STTRMLATTSPRTTA | 746 | Q7Z410 | |
| SSVQETSMLVSLLPT | 261 | Q9P2E3 | |
| ETLTSNLRMPLTLTS | 481 | Q9HC78 | |
| TAAMVLTSLSTSPLV | 86 | Q6ZNC4 | |
| ITLLPATTLMSLTDS | 86 | Q6ZNB5 | |
| RTDTTPVITSVMSLA | 621 | O95789 | |
| VLLVTSSFMSPSESR | 86 | P18887 | |
| TATLRILASMPSRTI | 76 | Q7Z403 | |
| LPSALSTSSLRASMT | 331 | Q92558 | |
| TAEISSTALRSSPIM | 1161 | O43314 | |
| PITLTVSTSSLNLMA | 231 | P29353 | |
| TMELSPRTLLSPSSI | 2791 | Q15911 |